[1] Schmeltzer PA,Talwalkar JA. Noninvasive tools to assess hepatic fibrosis:ready for prime time. Gastroenterol Clin North Am,2011,40(3):507-521. [2] Valva P,Casciato P,Diaz carrasco JM,et al. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.PLoS One,2011,6(8): e23218. [3] Ahmad W,Ijaz B,Javed FT,et al. A comparison of four fibrosis indexes in chronic HCV:Development of new fibrosis-cirrhosis index(FCI). BMC Gastroenterol,2011,11:44. [4] Wu SD,Wang JY,Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model:A comparative study. World J Gastroenterol,2010,16(4):501-507. [5] Poynard T,Ngo Y,Munteanu M,et al. Noninvasive markers of hepatic fibrosis in chronic hepatitis B. Curr Hepat Rep,2011,10:87-97. [6] Dowman JK,Tomlinson JW,Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther,2011,33:525-540. [7] Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int,2011,5:625-634. [8] Trang T,Petersen JR,Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: Comparison of the APRI and FIB-4 index. Clinica Chimica Acta,2008,397:51-54. [9] Güzelbulut F,etinkaya ZA,Sezikli M,et al. AST-platelet ratio index,Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C. Turk J Gastroenterol,2011,22(3):279-285. [10] Friedrich-rust M,Rosenberg W,Parkes J,et al. Comparison of ELF,FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol,2010,10:103. [11] Alkhouri N,Carter-kent C,Lopez R,et al. Combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol,2011,9(2):150-155. [12] Bourliere M,Penaranda G,Ouzan D,et al. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients. Aliment Pharmacol Ther,2008,28:458-467. [13] Sebastiani G,Halfon P,Castera L,et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology,2009,49:1821-1827. [14] Van de putte DF,Blom R,Van soest H,et al. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.Ann Hepatol,2011,10(4):469-476. [15] Castera L,Sebastiani G,Bail BL,et al. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol,2010,52:191-198. [16] Boursier J,Ledinghen V,Zarski JP,et al. A new combination of blood test and Fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol,2011,106(7):1255-1263. [17] Vergniol J,Foucher J,Terrebonne E,et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology,2011,140(7):1970-1979. |